Patents by Inventor Bridget Bax

Bridget Bax has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)
    Patent number: 10213492
    Abstract: The invention provides a method of treating mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) in a patient, comprising administering to the patient autologous erythrocytes that contain thymidine phosphorylase and are free of animal proteins other than proteins derived from the patient. The erythrocytes generally contain a low amount of endotoxin.
    Type: Grant
    Filed: September 3, 2012
    Date of Patent: February 26, 2019
    Assignee: St. George's Hospital Medical School
    Inventors: Bridget Bax, Murray Bain
  • TREATMENT FOR MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY (MNGIE)
    Publication number: 20140219980
    Abstract: The invention provides a method of treating mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) in a patient, comprising administering to the patient autologous erythrocytes that contain thymidine phosphorylase and are free of animal proteins other than proteins derived from the patient. The erythrocytes generally contain a low amount of endotoxin.
    Type: Application
    Filed: September 3, 2012
    Publication date: August 7, 2014
    Applicant: St. Georges Hospital Medical School
    Inventors: Bridget Bax, Murray Bain